Publications of the KKNMS
Your search in the archive “Publications of the KKNMS” returned the following results:
-
Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study
Von Bittner et al, erschienen in „EBioMedicine“ (Juni 2020)
-
Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF
Von Möhn et al, erschienen in „Neurol Neuroimmunol Neuroinflamm“ (Vol. 7, Nr. 2, März 2020)
-
T1-weighted intensity increase after a single administration of a linear gadolinium-based contrast agent in multiple sclerosis
Von Grahl at al, erschienen in „Clinical Neuroradiology“ (Februar 2020)
-
A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS
Von Rolfes at al, erschienen in „Neurol Neuroimmunol Neuroinflamm “ (Vol. 7, Nr. 1, Januar 2020)
-
Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab
Von Wiendl at al, erschienen in „Neurol Neuroimmunol Neuroinflamm “ (Vol. 7, Nr. 1, Januar 2020)
-
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis
Von Keller et al, erschienen in „Ann Clin Transl Neurol“ (Vol. 6, Nr. 12, Dezember 2019)
-
Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose
Von Bittner et al, erschienen in „Der Nervenarzt“ (Vol. 90, Nr. 12, Dezember 2019)
-
CD8(+) T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome
Von Gross et al, erschienen in „Nat Commun“ (Dezember 2019)
-
Temporal Dynamics of Diffusion Metrics in Early Multiple Sclerosis and Clinically Isolated Syndrome: A 2-Year Follow-Up Tract-Based Spatial Statistics Study
Von Schneider et al, erschienen in „Front Neurol“ (Vol. 10, Nr. 1165, November 2019)
-
Human CCR5high effector-memory cells perform CNS parenchymal immune surveillance via Granzyme K- mediated transendothelial diapedesis
Von Herich et al, erschienen in „Brain“ (Vol. 142, Nr. 11, November 2019)